Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.62) per share. This is a 40.91 percent decrease over losses of $(0.44) per share from the same period last year.
SVB Leerink Maintains Market Perform on Universal Health Services, Raises Price Target to $111
SVB Leerink analyst Whit Mayo maintains Universal Health Services (NYSE:UHS) with a Market Perform and raises the price target from $103 to $111.
